Search Results

There are 11010 results for: content related to: Evaluation of a vaporizing device (Volcano®) for the pulmonary administration of tetrahydrocannabinol

  1. You have free access to this content
    The effects of Δ9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide

    British Journal of Pharmacology

    Volume 145, Issue 4, June 2005, Pages: 514–526, Saoirse E O'Sullivan, David A Kendall and Michael D Randall

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0706218

  2. You have free access to this content
    Current knowledge on cannabinoids in oral fluid

    Drug Testing and Analysis

    Volume 6, Issue 1-2, January-February 2014, Pages: 88–111, Dayong Lee and Marilyn A. Huestis

    Version of Record online : 25 AUG 2013, DOI: 10.1002/dta.1514

  3. You have free access to this content
    Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties

    European Journal of Immunology

    Volume 40, Issue 12, December 2010, Pages: 3358–3371, Venkatesh L. Hegde, Mitzi Nagarkatti and Prakash S. Nagarkatti

    Version of Record online : 25 NOV 2010, DOI: 10.1002/eji.201040667

  4. You have free access to this content
    Δ9-Tetrahydrocannabinol inhibits electrically-evoked CGRP release and capsaicin-sensitive sensory neurogenic vasodilatation in the rat mesenteric arterial bed

    British Journal of Pharmacology

    Volume 152, Issue 5, November 2007, Pages: 709–716, J D Wilkinson, D A Kendall and V Ralevic

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0707448

  5. You have free access to this content
    Chronic Δ9-tetrahydrocannabinol treatment in rhesus monkeys: differential tolerance and cross-tolerance among cannabinoids

    British Journal of Pharmacology

    Volume 162, Issue 5, March 2011, Pages: 1060–1073, Lance R. McMahon

    Version of Record online : 28 JAN 2011, DOI: 10.1111/j.1476-5381.2010.01116.x

  6. You have free access to this content
    Reintoxication: the release of fat-stored Δ9-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure

    British Journal of Pharmacology

    Volume 158, Issue 5, November 2009, Pages: 1330–1337, N Gunasekaran, LE Long, BL Dawson, GH Hansen, DP Richardson, KM Li, JC Arnold and IS McGregor

    Version of Record online : 14 AUG 2009, DOI: 10.1111/j.1476-5381.2009.00399.x

  7. Long-term behavioral and pharmacodynamic effects of delta-9-tetrahydrocannabinol in female rats depend on ovarian hormone status

    Addiction Biology

    Volume 16, Issue 1, January 2011, Pages: 64–81, Peter J. Winsauer, Jill M. Daniel, Catalin M. Filipeanu, Stuart T. Leonard, Jerielle L. Hulst, Shaefali P. Rodgers, Caroline L. Lassen-Greene and Jessie L. Sutton

    Version of Record online : 23 JUN 2010, DOI: 10.1111/j.1369-1600.2010.00227.x

  8. Cannabis use: a perspective in relation to the proposed UK drug-driving legislation

    Drug Testing and Analysis

    Volume 6, Issue 1-2, January-February 2014, Pages: 143–154, Kim Wolff and Atholl Johnston

    Version of Record online : 11 DEC 2013, DOI: 10.1002/dta.1588

  9. You have free access to this content
    Novel Δ9-tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects

    British Journal of Clinical Pharmacology

    Volume 74, Issue 1, July 2012, Pages: 42–53, Linda E. Klumpers, Tim L. Beumer, Johan G. C. van Hasselt, Astrid Lipplaa, Lennard B. Karger, H. Daniël Kleinloog, Jan I. Freijer, Marieke L. de Kam and Joop M. A. van Gerven

    Version of Record online : 11 JUN 2012, DOI: 10.1111/j.1365-2125.2012.04164.x

  10. Effect of ion pairing on in vitro transcorneal permeability of a Δ9-tetrahydrocannabinol prodrug: Potential in glaucoma therapy

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 2, February 2012, Pages: 616–626, Tushar Hingorani, Waseem Gul, Mahmoud Elsohly, Michael A. Repka and Soumyajit Majumdar

    Version of Record online : 11 OCT 2011, DOI: 10.1002/jps.22791

  11. You have free access to this content
    Is a shutdown of the thermohaline circulation irreversible?

    Journal of Geophysical Research: Atmospheres (1984–2012)

    Volume 111, Issue D12, 27 June 2006, Jianjun Yin, Michael E. Schlesinger, Natasha G. Andronova, Sergey Malyshev and Bin Li

    Version of Record online : 22 JUN 2006, DOI: 10.1029/2005JD006562

  12. Distribution of ∆9-Tetrahydrocannabinol and 11-Nor-9-Carboxy-∆9-Tetrahydrocannabinol Acid in Postmortem Biological Fluids and Tissues From Pilots Fatally Injured in Aviation Accidents

    Journal of Forensic Sciences

    Volume 60, Issue 4, July 2015, Pages: 942–949, Philip M. Kemp, Patrick S. Cardona, Arvind K. Chaturvedi and John W. Soper

    Version of Record online : 19 MAR 2015, DOI: 10.1111/1556-4029.12751

  13. Taking the call-bell home: a qualitative evaluation of Tele-HomeCare for children

    Health & Social Care in the Community

    Volume 14, Issue 3, May 2006, Pages: 231–241, Nancy L. Young, Wendy Barden, Patricia McKeever, Paul T. Dick and The Tele-HomeCare Team

    Version of Record online : 23 MAR 2006, DOI: 10.1111/j.1365-2524.2006.00615.x

  14. Isomerization of delta-9-THC to delta-8-THC when tested as trifluoroacetyl-, pentafluoropropionyl-, or heptafluorobutyryl- derivatives

    Journal of Mass Spectrometry

    Volume 43, Issue 5, May 2008, Pages: 674–679, Justin M. Holler, Michael L. Smith, Shom N. Paul, Marilyn R. Past and Buddha D. Paul

    Version of Record online : 21 JAN 2008, DOI: 10.1002/jms.1375

  15. You have free access to this content
    Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ9-tetrahydrocannabinol in Sprague-Dawley rats

    British Journal of Pharmacology

    Volume 172, Issue 7, April 2015, Pages: 1783–1791, Michael A Taffe, Kevin M Creehan and Sophia A Vandewater

    Version of Record online : 23 JAN 2015, DOI: 10.1111/bph.13024

  16. Δ9-tetrahydrocannabinol and its major metabolite Δ9-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 3, March 2011, Pages: 1206–1211, Shuso Takeda, Rongrong Jiang, Hironori Aramaki, Masumi Imoto, Akihisa Toda, Reiko Eyanagi, Toshiaki Amamoto, Ikuo Yamamoto and Kazuhito Watanabe

    Version of Record online : 1 OCT 2010, DOI: 10.1002/jps.22354

  17. You have free access to this content
    Single dose delta-9-tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability

    British Journal of Clinical Pharmacology

    Volume 81, Issue 3, March 2016, Pages: 525–537, Marjan de Vries, Dagmar C. M. Van Rijckevorsel, Kris C. P. Vissers, Oliver H. G. Wilder-Smith and Harry Van Goor

    Version of Record online : 17 JAN 2016, DOI: 10.1111/bcp.12811

  18. Development and pharmacokinetic characterization of pulmonal and intravenous delta-9-tetrahydrocannabinol (THC) in humans

    Journal of Pharmaceutical Sciences

    Volume 93, Issue 5, May 2004, Pages: 1176–1184, Myrtha Naef, Stefan Russmann, Steen Petersen-Felix and Rudolf Brenneisen

    Version of Record online : 23 FEB 2004, DOI: 10.1002/jps.20037

  19. You have free access to this content
    Tetrahydrocannabinol-induced neurotoxicity depends on CB1 receptor-mediated c-Jun N-terminal kinase activation in cultured cortical neurons

    British Journal of Pharmacology

    Volume 140, Issue 3, October 2003, Pages: 547–557, Eric J Downer, Marie P Fogarty and Veronica A Campbell

    Version of Record online : 2 FEB 2009, DOI: 10.1038/sj.bjp.0705464

  20. Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking

    Drug Testing and Analysis

    Volume 7, Issue 6, June 2015, Pages: 494–501, Dayong Lee, Ryan Vandrey, Damodara R. Mendu, Jeannie A. Murray, Allan J. Barnes and Marilyn A. Huestis

    Version of Record online : 14 SEP 2014, DOI: 10.1002/dta.1718